glp-1 agonist indications Consensus Recommendations on RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy GLP-1 receptor agonists and next-generation
Description
Abtahi, S., Howell, E
The survey found 82% of poll participants had at least a little knowledge about the drugs, and 32% said they had heard a lot about them
Given Rezdiffras explosive sales growth, Novo may achieve the same outcome if authorities approve its drug
Other common adverse effects include injection site reactions, headache, and nasopharyngitis, but these effects do not usually result in discontinuation of the drug
Diabetes Ther Res Treat Educ Diabetes Rel Disorders
doi: 10.1007/s10549-011-1585-0 89 TanakaYIwayaCKawanamiTHamaguchiYHorikawaTShigeokaTet al
